These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27673323)

  • 41. [Effect and occurrence of synthetic cannabinoids].
    Tuv SS; Strand MC; Karinen R; Øiestad EL; Christophersen AS; Vindenes V
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2285-8. PubMed ID: 23736196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Notes from the Field: Acute Poisonings from a Synthetic Cannabinoid Sold as Cannabidiol - Utah, 2017-2018.
    Horth RZ; Crouch B; Horowitz BZ; Prebish A; Slawson M; McNair J; Elsholz C; Gilley S; Robertson J; Risk I; Hill M; Fletcher L; Hou W; Peterson D; Adams K; Vitek D; Nakashima A; Dunn A
    MMWR Morb Mortal Wkly Rep; 2018 May; 67(20):587-588. PubMed ID: 29795081
    [No Abstract]   [Full Text] [Related]  

  • 43. Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus.
    Grzeda E; Schlicker E; Luczaj W; Harasim E; Baranowska-Kuczko M; Malinowska B
    J Physiol Pharmacol; 2015 Jun; 66(3):343-53. PubMed ID: 26084216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The worldwide designer drug craze: bath salts behind the counter to get high: update for the clinical nurse specialist.
    O'Malley P
    Clin Nurse Spec; 2011; 25(5):224-5. PubMed ID: 22649842
    [No Abstract]   [Full Text] [Related]  

  • 45. A trip on "bath salts" is cheaper than meth or cocaine but much more dangerous.
    Slomski A
    JAMA; 2012 Dec; 308(23):2445-7. PubMed ID: 23288310
    [No Abstract]   [Full Text] [Related]  

  • 46. Plant cannabinoids: a neglected pharmacological treasure trove.
    Mechoulam R
    Br J Pharmacol; 2005 Dec; 146(7):913-5. PubMed ID: 16205721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T; Ueno S; Obara Y; Nakahata N
    J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
    Davis MP
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An apparent drop in synthetic cannabinoid presentations.
    Mason E
    N Z Med J; 2013 Dec; 126(1387):191. PubMed ID: 24362747
    [No Abstract]   [Full Text] [Related]  

  • 51. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.
    Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
    Ann Agric Environ Med; 2012; 19(4):857-70. PubMed ID: 23311820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA.
    Dobaja M; Grenc D; Kozelj G; Brvar M
    Clin Toxicol (Phila); 2017 Mar; 55(3):193-195. PubMed ID: 28084855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease.
    Laprairie RB; Kelly ME; Denovan-Wright EM
    Neuropharmacology; 2013 Sep; 72():47-57. PubMed ID: 23602984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions.
    Mendizábal VE; Adler-Graschinsky E
    Br J Pharmacol; 2007 Jun; 151(4):427-40. PubMed ID: 17450170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mephedrone, the new designer drug of abuse: pharmacokinetics, pharmacodynamics and clinical and forensic issues].
    Ribeiro E; Magalhães T; Dinis-Oliveira RJ
    Acta Med Port; 2012; 25(2):111-7. PubMed ID: 22985922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implementation of the 2013 Psychoactive Substances Act and mental health harms from synthetic cannabinoids.
    Glue P; Courts J; MacDonald M; Gale C; Mason E
    N Z Med J; 2015 May; 128(1414):15-8. PubMed ID: 26117386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolism and toxicological analysis of synthetic cannabinoids in biological fluids and tissues.
    Presley BC; Gurney SM; Scott KS; Kacinko SL; Logan BK
    Forensic Sci Rev; 2016 Jul; 28(2):103-69. PubMed ID: 27257717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthetic cannabinoid drug use as a cause or contributory cause of death.
    Labay LM; Caruso JL; Gilson TP; Phipps RJ; Knight LD; Lemos NP; McIntyre IM; Stoppacher R; Tormos LM; Wiens AL; Williams E; Logan BK
    Forensic Sci Int; 2016 Mar; 260():31-39. PubMed ID: 26795398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthetic cannabis.
    Westin AA; Brede WR; Espnes KA
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2289. PubMed ID: 23736197
    [No Abstract]   [Full Text] [Related]  

  • 60. Epidemiological study of acute poisoning in children: a 5-year retrospective study in the Paediatric University Hospital in Białystok, Poland.
    Pawłowicz U; Wasilewska A; Olański W; Stefanowicz M
    Emerg Med J; 2013 Sep; 30(9):712-6. PubMed ID: 22942363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.